mktcap_usd=120073
ConsensRecom=2.15
earning_yield=6.85%
growth=4.48%
dilution=-0.51%
div_ratio=43.32%
sh_payout_ratio=50.53%
margin=17.63%
cfmargin=11.66%
ratiopaid=77.65%
sratiopaid=30.13%
ratioConsens=1.12
Description
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofis Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Companys products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
Income and Cashflow Statements EUR
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2019-03-11 | 2018-07-31 | 2019-03-11 | 2022-02-23 | 2022-02-23 | 2022-02-23 | 2023-02-24 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 34696 | 36221 | 35677 | 37631 | 37369 | 39175 | 45389 | 38023 | 3559 |
| revgrowth | NaN | 4.30% | -1.51% | 5.33% | -0.70% | 4.72% | 14.72% | 4.48% | 5.80% |
| earn | 4709 | 8416 | 4306 | 2754 | 12294 | 6223 | 8371 | 6725 | 3228 |
| earnx | 4395 | 3773 | 4319 | 2855 | 12294 | 6223 | 8371 | 6033 | 3305 |
| margin | 13.57% | 23.24% | 12.07% | 7.32% | 32.90% | 15.89% | 18.44% | 17.63% | 8.39% |
| xmargin | 12.67% | 10.42% | 12.11% | 7.59% | 32.90% | 15.89% | 18.44% | 15.71% | 8.36% |
| earningyld | 4.75% | 9.31% | 4.43% | 2.52% | 11.94% | 5.73% | 7.38% | 6.58% | 3.21% |
| cfop | 7853 | 7379 | 5547 | 7715 | 7418 | 10522 | 10526 | 8137 | 1801 |
| cfinv | -2637 | 639 | -12872 | -1029 | 3619 | -7298 | -2075 | -3093 | 5444 |
| cffin | -3990 | -7902 | 3934 | -4193 | -6485 | -7056 | -5821 | -4502 | 3985 |
| cfopmargin | 22.63% | 20.37% | 15.55% | 20.50% | 19.85% | 26.86% | 23.19% | 21.28% | 3.49% |
| cfinvmargin | -7.60% | 1.76% | -36.08% | -2.73% | 9.68% | -18.63% | -4.57% | -8.31% | 14.99% |
| cffinmargin | -11.50% | -21.82% | 11.03% | -11.14% | -17.35% | -18.01% | -12.82% | -11.66% | 10.74% |
| shares | 1300 | 1271 | 1259 | 1261 | 1264 | 1262 | 1261 | 1268 | 14.5 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 76.2 | 71.1 | 77.2 | 86.6 | 81.5 | 86.1 | 89.9 | 81.2 | 6.73 |
| dilution | NaN | -2.28% | -0.92% | 0.15% | 0.24% | -0.17% | -0.08% | -0.51% | 0.96% |
| dividend | 3759 | 3710 | 3773 | 3834 | 3937 | 4008 | 4168 | 3884 | 163 |
| sharebb | NaN | 2158 | 863 | -156 | -253 | 185 | 88.3 | 481 | 911 |
| ltdebtbb | NaN | 2456 | -7762 | 903 | 443 | 1710 | 1968 | -47.0 | 3849 |
| mgtbb | NaN | 422 | 808 | 388 | -2358 | -1153 | 403 | -248 | 1238 |
| divyld | 3.79% | 4.11% | 3.88% | 3.51% | 3.82% | 3.69% | 3.68% | 3.78% | 0.19% |
| sharebbyld | NaN | 2.28% | 0.92% | -0.15% | -0.24% | 0.17% | 0.08% | 0.51% | 0.96% |
| mgtyld | NaN | 0.47% | 0.83% | 0.36% | -2.29% | -1.06% | 0.36% | -0.22% | 1.20% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2019-03-11 | 2018-07-31 | 2019-03-11 | 2022-02-23 | 2022-02-23 | 2022-02-23 | 2023-02-24 | NaN | NaN |
| mktcap | 99124 | 90369 | 97218 | 109231 | 102991 | 108641 | 113362 | 102991 | 8021 |
| mktcapgrowth | NaN | -9.25% | 7.31% | 11.65% | -5.88% | 5.34% | 4.25% | 2.24% | 8.07% |
| totAsset | 104679 | 99813 | 111408 | 112630 | 114413 | 120242 | 126722 | 112844 | 9022 |
| assetgrowth | NaN | -4.76% | 10.99% | 1.09% | 1.57% | 4.97% | 5.25% | 3.18% | 5.26% |
| curAsset | 26691 | 26354 | 24579 | 28611 | 33703 | 30564 | 34026 | 29218 | 3686 |
| curAssetPct | 25.50% | 26.40% | 22.06% | 25.40% | 29.46% | 25.42% | 26.85% | 25.87% | 2.21% |
| totLiab | 47127 | 41743 | 52532 | 53574 | 51307 | 51561 | 51938 | 49969 | 4154 |
| totLiabPct | 45.02% | 41.82% | 47.15% | 47.57% | 44.84% | 42.88% | 40.99% | 44.32% | 2.54% |
| curLiab | 16443 | 15463 | 17376 | 20381 | 19248 | 21295 | 23964 | 19167 | 2982 |
| curLiabPct | 15.71% | 15.49% | 15.60% | 18.10% | 16.82% | 17.71% | 18.91% | 16.91% | 1.37% |
| ltDebt | 16765 | 14309 | 22071 | 21168 | 20725 | 19015 | 17047 | 18729 | 2811 |
| ltDebtPct | 16.02% | 14.34% | 19.81% | 18.79% | 18.11% | 15.81% | 13.45% | 16.62% | 2.36% |
| Equity | 57552 | 58070 | 58876 | 59056 | 63106 | 68681 | 74784 | 62875 | 6552 |
| EquityPct | 54.98% | 58.18% | 52.85% | 52.43% | 55.16% | 57.12% | 59.01% | 55.68% | 2.54% |
| PB | 1.72 | 1.56 | 1.65 | 1.85 | 1.63 | 1.58 | 1.52 | 1.64 | 11.30% |
Beta
len=129
mean=2.14%
sd=17.90%
alpha=0.07%
beta=35.63%
r_sq=12.77%
lastdate=2023-03-21
firstdate=2013-02-01
logret1y=-2.72%
Financial Snapshot
CompanyName=Sanofi SA
ID=1
Name=Ordinary Shares
Ticker=SAN
ISIN=FR0000120578
RIC=SASY.PA
DisplayRIC=SASY.PA
InstrumentPI=433480
QuotePI=721130
InstrumentPermID=8590932832
QuotePermID=55835473115
Exchange=Euronext Paris
ExchangeCode=EPA
ExchangeCountry=FRA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-15
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=91573
SharesOut=1.253e+09
TotalFloat=1.112e+09
ReportingCurrency=EUR
MostRecentExchange=0.94295
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=89.8
NHIG=106
NLOW=76.5
PDATE=2023-03-17
VOL10DAVG=2.03
EV=121325
MKTCAP=113223
AREV=45389
AEBITD=13727
ANIAC=8371
AEPSXCLXOR=6.66
AREVPS=36.1
ABVPS=59.7
ACSHPS=10.7
ACFSHR=9.62
ADIVSHR=3.56
AGROSMGN=69.8
AROEPCT=11.7
APR2REV=2.49
APEEXCLXOR=13.5
APRICE2BK=1.50
ConsRecom=2.15
TargetPrice=100
ProjLTGrowthRate=10.2
ProjPE=10.9
ProjSales=45086
ProjSalesQ=10458
ProjEPS=8.25
ProjEPSQ=2.04
ProjProfit=11211
ProjDPS=3.70
quoteccy=EUR
quotefx=94.30%
exchgccy=EUR
exchgfx=94.30%
tick=None
exchg=None
Valuation
ticker=SAN
exchg=SBF
RIC=SASY.PA
CompanyName=Sanofi SA
ExchangeCode=EPA
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=eu
ccy=EUR
fx=94.30%
mktcap_usd=120073
float_usd=106628
ConsensRecom=2.15
earning_yield=6.85%
growth=4.48%
dilution=-0.51%
margin=17.63%
searning_yield=3.83%
sgrowth=-0.82%
smargin=9.87%
sdilution=0.36%
projearning_yield=8.79%
earning_excl_yield=7.15%
div_ratio=43.32%
bb_ratio=7.21%
sh_payout_ratio=50.53%
PS=2.49
price=89.8
ratio=77.65%
sratio=30.13%
sratiopaid=30.13%
ratioConsens=1.12
turnover=33.70%
cfmargin=11.66%
rdmargin=15.22%
scfmargin=1.72%
quoteccy=EUR
quotefx=94.30%
ratiopaid=77.65%
dt=2023-03-17
assetgrowth=3.19%
dlnfx=0.27%